FindTrial
Sign In

Clinical study of the effect of Urokinase and heparin sodium used alternately to seal tube alternately on hemodialysis patients with a permanent catheter

Clinical study of the effect of Urokinase and heparin sodium used alternately to seal tube alternately on hemodialysis patients with a permanent catheter

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13004389
Enrollment
Unknown
Registered
2013-07-22
Start date
2013-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis patient with a permanent catheter

Interventions

The experimental group:Urokinase heparin alternating sealed tube
Control group:Heparin sealed tube

Sponsors

Department of Nephrology, Zhongda Hospital Affiliated to Southeast University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) the internal jugular vein indwelling catheter in patients with long-term, regular hemodialysis for 3 months; (2) 3 times weekly dialysis, every time 4 ~ 4.5 hours; (3) without disturbance of consciousness.

Exclusion criteria

Exclusion criteria: (1) severe anemia, hematological system disease, bleeding and bleeding tendency; (2) Receiv long-term systemic anticoagulation therapy patients; (3) intracranial or spinal tumor patients; (4) pregnant.

Design outcomes

Primary

MeasureTime frame
PT;APTT;PLT;Catheter dysfunction occurrence;—

Countries

China

Contacts

Public ContactTony
tonyxlz@163.com+86 13852290358

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026